Related Experiment Video
Updated: Aug 7, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Predictive value of in vitro safety studies
1Exploratory Development, Safety Profiling and Assessment, Novartis Pharma AG, CH 4002 Basel, Switzerland. willi.suter@novartis.com
Abstract:
The predictive value of in vitro safety studies is discussed for three important areas of pharmaceutical safety evaluations. In genetic toxicology, currently assays are sensitive for the prediction of cancer, but their overall predictive value is strongly diminished because of their low specificity. In the area of safety pharmacology blockage of hERG channel in vitro has recently been introduced to predict cardiac repolarization delay (QT interval prolongation) in patients. There is a plethora of in vitro methods to predict and characterize liver toxicity. However, little data is available that demonstrate a reliable prediction for hepatotoxicity in vivo over a wide range of chemical structures. In all three areas, further improvements are needed. 'Omics' technologies and new cell lines derived from stem cells are expected to strongly contribute to establish new and more predictive in vitro assays.
Related Concept Videos
Toxicity Testing in Animals
In Vitro Drug Release Testing: Overview, Development and Validation
Mutagenicity and Carcinogenicity
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

